Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Today, antibiotics are the third largest-selling class of drugs, with a worldwide annual market estimated between $7 and $22 billion.

In this work, authors show that exclusive breastfeeding reduces antimicrobial resistance gene burden in infants by promoting Bifidobacterium, counteracting C-section and antibiotic effects, and ...